miR-105 Inhibits Prostate Tumour Growth by Suppressing CDK6 Levels

• D. Rice Honeywell,

  Affiliations Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, Departments of Biochemistry Microbiology and Immunology, University of Ottawa, Ontario, Canada

  ⨯
• Miguel A. Cabrita,

  Current address: Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada

  Affiliation Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

  ⨯
• Huijun Zhao,

  Affiliation Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

  ⨯
• Jim Dimitroulakos,

  Affiliations Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, Departments of Biochemistry Microbiology and Immunology, University of Ottawa, Ontario, Canada, Department of Medicine, University of Ottawa, Ontario, Canada

  ⨯
• Christina L. Addison

  * E-mail: caddison@ohri.ca

  Affiliations Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada, Departments of Biochemistry Microbiology and Immunology, University of Ottawa, Ontario, Canada, Department of Medicine, University of Ottawa, Ontario, Canada

  ⨯